Research!America’s 2016 National Health Research Forum will tackle relevant and cutting-edge issues on medical research and innovation Thursday, September 8, 11:30 a.m. – 3:00 p.m. ET, at the Newseum in Washington, D.C. As policymakers explore ways to modernize our research ecosystem to benefit patients and bring researchers together to work toward national initiatives, experts representing various sectors of the research community will discuss the future of medical progress.
The first panel, moderated by Nsikan Akpan, digital science producer for PBS NewsHour, will discuss national initiatives, such as the BRAIN initiative and the cancer moonshot, looking at the progress and promise of such programs, and current health challenges including the Zika virus. Panelists will include France A. Córdova, Ph.D., director, National Science Foundation; Donna R. Cryer, JD, president and CEO, Global Liver Institute; John W. Danaher, M.D., MBA, president, Elsevier Education, Elsevier; Anthony S. Fauci, M.D., director, National Institute of Allergy and Infectious Diseases; Albert A. Lauritano, M.S., CLP, director, strategic technology partnerships, BD; and Keith R. Yamamoto, Ph.D., vice chancellor for research, executive vice dean of the school of medicine, and professor of cellular and molecular pharmacology, University of California, San Francisco.
Natalie Azar, M.D., medical contributor for NBC news, will moderate the second panel, which will look at the importance of prevention research in forestalling and addressing public health threats, such as antibiotic resistance and the opioid epidemic. Panelists are Hortensia Amaro, Ph.D., associate vice provost for community research initiatives and dean's professor of social work and preventive medicine, University of Southern California; Andrew B. Bindman, M.D., director, Agency for Healthcare Research and Quality; Thomas R. Frieden, M.D., MPH, director, Centers for Disease Control and Prevention; William N. Hait, M.D., Ph.D., global head, Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson; Joe V. Selby, M.D., MPH, executive director, Patient-Centered Outcomes Research Institute; and Stephen D. Silberstein, M.D., FAHS, FACP, professor of neurology and director of the Jefferson Headache Center, Thomas Jefferson University.
Geneva Overholser, a senior fellow and consultant at the Democracy Fund, will moderate the third panel and explore the role of the Food and Drug Administration in delivering on the promise of regenerative medicine, precision medicine and other scientific breakthroughs. Panelists include Robert M. Califf, M.D., commissioner, the Food and Drug Administration; Emil Kakkis, M.D., Ph.D., president and founder, EveryLife Foundation for Rare Diseases; and The Honorable Kweisi Mfume, former U.S. Representative, 1987-1996; Sudip S. Parikh, Ph.D., senior vice president and managing director, DIA Global; and Jean-Christophe Tellier, M.D., CEO, UCB.
Janssen Pharmaceutical Companies of Johnson & Johnson is the lead sponsor of the event. Panel sponsors include AdvaMed, Amgen, BD, Elsevier and PCORI. For more information and a full list of sponsors, visit researchamerica.org/forum.